The idea isn’t the problem
Every week, a clinician somewhere has a genuine insight: a pattern in patient outcomes that could be predicted, a decision point that could be supported by data, a monitoring gap that wearables could fill.
The insight is usually sound. The clinical expertise is real. The data exists.
And yet most of these projects never ship.
The structural gap
The problem isn’t that clinicians lack good ideas. It’s that the path from clinical insight to deployed, FDA-aware application requires a set of capabilities that don’t naturally live in the same person:
- Product design — translating a clinical workflow into a usable interface
- System architecture — choosing the right technical stack for regulatory constraints
- Regulatory navigation — IEC 62304, ISO 14971, FDA Class II SaMD pathways
- Implementation — actually building and deploying the application
Most clinicians try to solve this by hiring a development shop. The dev shop builds what they’re told, but they don’t understand clinical workflows, regulatory requirements, or how to structure a Design History File. The result is an application that works technically but can’t survive regulatory scrutiny.
What a clinical AI project actually needs
The projects that ship share a common structure: clinical expertise paired with technical leadership that understands both the product and the regulatory landscape.
This isn’t about finding a developer. It’s about finding a technical cofounder — someone who can own the architecture, navigate the regulatory pathway, and make product decisions that account for clinical reality.
That’s the gap GluonLabs exists to fill.
Building a clinical AI application? Book a free scoping call to discuss your project.